These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for Kim EH; Siegel BA; Teoh EJ; Andriole GL; Urol Oncol; 2021 Jun; 39(6):365.e9-365.e16. PubMed ID: 33160848 [TBL] [Abstract][Full Text] [Related]
7. Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using Miller MP; Kostakoglu L; Pryma D; Yu JQ; Chau A; Perlman E; Clarke B; Rosen D; Ward P J Nucl Med; 2017 Oct; 58(10):1596-1602. PubMed ID: 28385791 [No Abstract] [Full Text] [Related]
8. [ Zanoni L; Bianchi L; Nanni C; Pultrone C; Giunchi F; Bossert I; Matti A; Schiavina R; Fiorentino M; Romagnoli D; Fonti C; Lodi F; D'Errico A; Brunocilla E; Porreca A; Fanti S Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):390-409. PubMed ID: 34213609 [TBL] [Abstract][Full Text] [Related]
10. Effect of hormonal therapy on Bulbul JE; Hashem A; Grybowski D; Joyce C; Rashad E; Gabriel MS; Wagner RH; Savir-Baruch B Urol Oncol; 2022 Aug; 40(8):379.e9-379.e16. PubMed ID: 35738974 [TBL] [Abstract][Full Text] [Related]
11. The Clinical Utility of Nakamoto R; Harrison C; Song H; Guja KE; Hatami N; Nguyen J; Moradi F; Franc BL; Aparici CM; Davidzon G; Iagaru A Mol Imaging Biol; 2021 Aug; 23(4):614-623. PubMed ID: 33469884 [TBL] [Abstract][Full Text] [Related]
12. Real-world evidence of Friedrich NA; Gu L; Waller J; De Hoedt AM; Klaassen Z; Freedland SJ Prostate; 2024 Oct; 84(14):1336-1343. PubMed ID: 39031050 [TBL] [Abstract][Full Text] [Related]
13. The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial. Andriole GL; Kostakoglu L; Chau A; Duan F; Mahmood U; Mankoff DA; Schuster DM; Siegel BA; J Urol; 2019 Feb; 201(2):322-331. PubMed ID: 30179618 [TBL] [Abstract][Full Text] [Related]
14. Utility of Galgano SJ; McDonald AM; Rais-Bahrami S; Porter KK; Choudhary G; Burgan C; Bhambhvani P; Nix JW; Morgan DE; Li Y; Thomas JV; McConathy J AJR Am J Roentgenol; 2021 Sep; 217(3):720-729. PubMed ID: 33052718 [No Abstract] [Full Text] [Related]
15. A PET/MRI study towards finding the optimal [ Elschot M; Selnæs KM; Sandsmark E; Krüger-Stokke B; Størkersen Ø; Tessem MB; Moestue SA; Bertilsson H; Bathen TF Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):695-703. PubMed ID: 27817158 [TBL] [Abstract][Full Text] [Related]
16. Prospective Evaluation of Song H; Harrison C; Duan H; Guja K; Hatami N; Franc BL; Moradi F; Aparici CM; Davidzon GA; Iagaru A J Nucl Med; 2020 Apr; 61(4):546-551. PubMed ID: 31628216 [No Abstract] [Full Text] [Related]
17. Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study. Tade FI; Cohen MA; Styblo TM; Odewole OA; Holbrook AI; Newell MS; Savir-Baruch B; Li X; Goodman MM; Nye JA; Schuster DM J Nucl Med; 2016 Sep; 57(9):1357-63. PubMed ID: 27056619 [TBL] [Abstract][Full Text] [Related]
18. PSMA-targeted Radiotracers versus Tan N; Oyoyo U; Bavadian N; Ferguson N; Mukkamala A; Calais J; Davenport MS Radiology; 2020 Jul; 296(1):44-55. PubMed ID: 32396045 [TBL] [Abstract][Full Text] [Related]
19. 18F-Fluciclovine Uptake in Celiac Ganglia: A Pitfall in Prostate Cancer PET Imaging. Wo S; Matesan MC Clin Nucl Med; 2019 Sep; 44(9):743-745. PubMed ID: 31283598 [TBL] [Abstract][Full Text] [Related]
20. Differential 18F-FDG and 18F-Fluciclovine Uptake Pattern in a Patient With Poorly Differentiated Adenocarcinoma of the Lung and Prostate Cancer Biochemical Recurrence. Nguyen NC; Muthukrishnan A; Mountz JM Clin Nucl Med; 2020 Jan; 45(1):e63-e64. PubMed ID: 31652158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]